We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+8.8%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$46.2B
AUM Growth
+$1.83B
(+4.1%)
Cap. Flow
-$543M
Cap. Flow
% of AUM
-1.17%
Top 10 Holdings %
Top 10 Hldgs %
24.86%
Holding
1,809
New
24
Increased
1,140
Reduced
325
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$98M |
| 2 |
Kinder Morgan
KMI
|
+$97.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$96.6M |
| 4 |
UnitedHealth
UNH
|
+$77.5M |
| 5 |
Marriott International
MAR
|
+$58.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$198M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$179M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$162M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$154M |
| 5 |
Bank of America
BAC
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.89% |
| 2 | Healthcare | 18.49% |
| 3 | Financials | 11.85% |
| 4 | Consumer Discretionary | 9.1% |
| 5 | Industrials | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Nabors Industries
NBR
$1.12B
| $482K | ﹤0.01% |
3,950
+1,350
| +52% | +$204K |
|
1652
ANI Pharmaceuticals
ANIP
$1.84B
| $478K | ﹤0.01% |
12,033
+500
| +4% | +$21.1K |
|
1653
Beyond Meat
BYND
$279M
| $475K | ﹤0.01% |
+29,250
| New | +$482K |
|
|
PACW
1654
DELISTED
PacWest Bancorp
PACW
| $471K | ﹤0.01% |
48,406
+50
| +0.1% | +$1.11K |
|
1655
HealthStream
HSTM
$843M
| $469K | ﹤0.01% |
17,310
| – | – |
|
|
SPWR
1656
DELISTED
SunPower Corporation Common Stock
SPWR
| $467K | ﹤0.01% |
33,760
+4,700
| +16% | +$73.7K |
|
1657
Semtech
SMTC
$10.4B
| $467K | ﹤0.01% |
19,343
-7,942
| -29% | -$248K |
|
|
KREF
1658
KKR Real Estate Finance Trust
KREF
$471M
| $466K | ﹤0.01% |
40,900
+14,800
| +57% | +$208K |
|
|
CIR
1659
DELISTED
CIRCOR International, Inc
CIR
| $450K | ﹤0.01% |
14,450
+1,600
| +12% | +$43.7K |
|
1660
Archrock
AROC
$6.19B
| $450K | ﹤0.01% |
46,020
| – | – |
|
|
DCH
1661
Dauch Corp
DCH
$1.33B
| $448K | ﹤0.01% |
57,400
| – | – |
|
|
AAMI
1662
Acadian Asset Management
AAMI
$2.94B
| $447K | ﹤0.01% |
18,970
+1,900
| +11% | +$44.7K |
|
1663
RE/MAX Holdings
RMAX
$206M
| $441K | ﹤0.01% |
23,533
+5,950
| +34% | +$118K |
|
1664
Donnelley Financial Solutions
DFIN
$1.31B
| $440K | ﹤0.01% |
10,774
+100
| +0.9% | +$4.25K |
|
1665
Apogee Enterprises
APOG
$873M
| $436K | ﹤0.01% |
10,085
+2,000
| +25% | +$89.8K |
|
1666
Varex Imaging
VREX
$469M
| $436K | ﹤0.01% |
23,975
| – | – |
|
1667
Encore Capital Group
ECPG
$2.06B
| $435K | ﹤0.01% |
8,623
+700
| +9% | +$36.6K |
|
1668
El Pollo Loco
LOCO
$497M
| $434K | ﹤0.01% |
45,270
+6,300
| +16% | +$71.7K |
|
1669
Comstock Resources
CRK
$3.64B
| $432K | ﹤0.01% |
40,040
| – | – |
|
1670
Anika Therapeutics
ANIK
$202M
| $428K | ﹤0.01% |
14,900
+4,200
| +39% | +$125K |
|
|
NXGN
1671
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $428K | ﹤0.01% |
24,574
+150
| +0.6% | +$2.7K |
|
1672
E.W. Scripps
SSP
$282M
| $427K | ﹤0.01% |
45,334
+5,000
| +12% | +$62.9K |
|
1673
Usana Health Sciences
USNA
$429M
| $426K | ﹤0.01% |
6,770
+900
| +15% | +$53.7K |
|
1674
AdaptHealth
AHCO
$1.53B
| $425K | ﹤0.01% |
34,210
+2,550
| +8% | +$46.9K |
|
1675
Upstart Holdings
UPST
$2.66B
| $423K | ﹤0.01% |
+26,600
| New | +$448K |
|
Similar funds
SCP
Ensign Peak Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Ensign Peak Advisors held 1,809 positions worth $46.2B, up 4.1% from $44.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 3.4%. Ensign Peak Advisors opened 24 new positions and exited 37, leaving the 1,809-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q1 2023 buy was State Street Financial Select Sector SPDR ETF: 1,117,296 shares worth $35.9M.
- Ensign Peak Advisors added most to Eli Lilly in Q1 2023, an estimated $98M increase.
- Ensign Peak Advisors's biggest Q1 2023 reduction was First Republic Bank, cutting an estimated $198M.
- Ensign Peak Advisors fully exited iShares Russell 2000 ETF in Q1 2023, selling an estimated $179M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $46.2B portfolio in Q1 2023.
- Ensign Peak Advisors opened 24 new positions and closed 37 in Q1 2023.
- Ensign Peak Advisors's portfolio value rose 4.1% quarter-over-quarter to $46.2B.
Based on Ensign Peak Advisors's 13F filing for Q1 2023, filed 15 May 2023.